The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > REGULATORY
REGULATORY
- AMED Chief-to-Be Vows to Overhaul Siloed Research Grants
January 19, 2015
- PMDA Head Expresses Full Support for AMED
January 19, 2015
- 112.8 Billion Yen Allotted to Intractable Disease Measures
January 19, 2015
- 65 Institutions to Treat Post-HPV Vaccine Adverse Reactions
January 16, 2015
- MHLW to Reorganize Health Service Bureau in FY2015
January 16, 2015
- LDP’s Takemi Says NHI Prices Will Probably Be Cut for 3 Years in a Row
January 16, 2015
- MHLW Approves Plan to Include Hepatitis B Vaccines in Public Vaccination Programs
January 16, 2015
- 1.9 Billion Yen Allocated to Speed Up Regulatory Reviews
January 15, 2015
- 124.8 Billion Yen Earmarked in FY2015 Budget for AMED
January 15, 2015
- AJMC to Announce Guidelines for Investigator-Led Clinical Trials Next Month
January 15, 2015
- Japan Govt OKs FY2015 Tax Reform Plan
January 15, 2015
- Editor’s Pick: Five Healthcare News Headlines for Dec. 29 - Jan. 11
January 14, 2015
- Cabinet OKs Extra Budget, 3.5 Billion Yen Allocated for IFN-Free Treatment
January 13, 2015
- Panel Agrees to Add Hepatitis B Vaccines to Public Immunization Program
January 13, 2015
- MHLW Calls for Revision of Package Inserts for SGLT-2 Inhibitors
January 13, 2015
- FY2015 Budget to Earmark 47 Billion Yen to Promote Healthcare R&D
January 9, 2015
- PAFSC 2nd Committee to Discuss Eisai’s Anticancer Agent on Jan. 21
January 9, 2015
- 30% R&D Tax Deduction Cap Could Be Secured with Open Innovation Tax Break: Economic Affairs Division
January 8, 2015
- 2015 to Be “Starting Year for Major Reform” of Healthcare and Nursing Insurance Systems: Health Minister
January 8, 2015
- Public Trust Indispensable for Industry Development: Mr Futagawa of Health Policy Bureau
January 7, 2015
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…